engineered insulin analogues (Thermalin/Sanofi)

N/A

Report date: 2025/03/20 15:16:20

Base Information

Drug Nameengineered insulin analogues (Thermalin/Sanofi)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInsulin ligandInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThermalin Diabetes Llc
China Registration ClassN/A

Develop Information

Active CompaniesThermalin Diabetes LlcSanofi
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A